{"transactions":[{"id":744293,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":35663,"kind":"person","name":"Satvat Ali J.","position":1,"cik":"0001621788","reported_name":"Satvat Ali J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T01:57:30.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000206","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000206/form4.xml","form_type":"4"}},{"id":744292,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":35663,"kind":"person","name":"Satvat Ali J.","position":1,"cik":"0001621788","reported_name":"Satvat Ali J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-10T01:57:30.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000206/form4.xml","form_type":"4"}},{"id":744291,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":11505,"kind":"person","name":"Karachun Rita A","position":1,"cik":"0001601572","reported_name":"Karachun Rita A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:43:22.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000205","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000205/form4.xml","form_type":"4"}},{"id":744290,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":11505,"kind":"person","name":"Karachun Rita A","position":1,"cik":"0001601572","reported_name":"Karachun Rita A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:43:22.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000205/form4.xml","form_type":"4"}},{"id":744289,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:42:41.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000204","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000204/form4.xml","form_type":"4"}},{"id":744288,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:42:41.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000204","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000204/form4.xml","form_type":"4"}},{"id":744287,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39971,"kind":"person","name":"Ryan Michael Lee","position":1,"cik":"0001985918","reported_name":"Ryan Michael Lee","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:41:31.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000203","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000203/form4.xml","form_type":"4"}},{"id":744286,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39971,"kind":"person","name":"Ryan Michael Lee","position":1,"cik":"0001985918","reported_name":"Ryan Michael Lee","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:41:31.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000203","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000203/form4.xml","form_type":"4"}},{"id":744285,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39970,"kind":"person","name":"O'Donnell-Tormey Jill","position":1,"cik":"0001927733","reported_name":"O'Donnell-Tormey Jill","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:41:03.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000202","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000202/form4.xml","form_type":"4"}},{"id":744284,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39970,"kind":"person","name":"O'Donnell-Tormey Jill","position":1,"cik":"0001927733","reported_name":"O'Donnell-Tormey Jill","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:41:03.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000202/form4.xml","form_type":"4"}},{"id":744517,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:40:24.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000201","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071726000201/form4.xml","form_type":"4"}},{"id":744516,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:40:24.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071726000201/form4.xml","form_type":"4"}},{"id":744804,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":21269,"kind":"person","name":"Newton Charles W.","position":1,"cik":"0001866219","reported_name":"Newton Charles W.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:39:55.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000200","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866219/000161071726000200/form4.xml","form_type":"4"}},{"id":744803,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":21269,"kind":"person","name":"Newton Charles W.","position":1,"cik":"0001866219","reported_name":"Newton Charles W.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:39:55.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866219/000161071726000200/form4.xml","form_type":"4"}},{"id":754209,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":30000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754208,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754207,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754206,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from September 7, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754205,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":25000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754204,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754203,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754202,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2033-03-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754201,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.87,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754200,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from September 7, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.78,"expiration_date":"2032-09-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754199,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.67,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754198,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.76,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754550,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":225000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754549,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":402500,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754548,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":402500,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754547,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":125000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754546,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":500000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754545,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":500000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754544,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":450000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754543,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":400000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754542,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":200000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754541,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754540,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.37,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754539,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":402500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.94,"expiration_date":"2032-01-04","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754538,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.6,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754537,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.33,"expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754536,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754535,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754534,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":754533,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:29:43.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-069621","document":"tm2616725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000110465926069621/tm2616725-1_4seq1.xml","form_type":"4"}},{"id":931119,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T21:40:58.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 23, 2026 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":750000,"derivative":{"exercise_price":2.06,"expiration_date":"2036-01-23","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001610717-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071726000027/form4.xml","form_type":"4"}},{"id":931118,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-26T21:40:58.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest on May 20, 2027 and 50% of the RSUs vest on March 20, 2029, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":1048235,"source":{"system":"sec-edgar","filing":"0001610717-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071726000027/form4.xml","form_type":"4"}},{"id":931037,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T21:39:43.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 22, 2026 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001610717-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000026/form4.xml","form_type":"4"}},{"id":931036,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:39:43.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest on May 20, 2027 and 50% of the RSUs vest on March 20, 2029, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":133736,"source":{"system":"sec-edgar","filing":"0001610717-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000026/form4.xml","form_type":"4"}},{"id":933204,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T01:50:42.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1715,"price":1.55,"value":2658.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":21236,"source":{"system":"sec-edgar","filing":"0001610717-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000017/form4.xml","form_type":"4"}},{"id":933345,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-23T01:50:01.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":11839,"price":1.55,"value":18350.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":673235,"source":{"system":"sec-edgar","filing":"0001610717-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071726000016/form4.xml","form_type":"4"}},{"id":1111119,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39970,"kind":"person","name":"O'Donnell-Tormey Jill","position":1,"cik":"0001927733","reported_name":"O'Donnell-Tormey Jill","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:50:52.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000229","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000229/form4.xml","form_type":"4"}},{"id":1111118,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:50:17.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000228","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000228/form4.xml","form_type":"4"}},{"id":1111496,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:49:51.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071725000227/form4.xml","form_type":"4"}},{"id":1111117,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39971,"kind":"person","name":"Ryan Michael Lee","position":1,"cik":"0001985918","reported_name":"Ryan Michael Lee","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:49:24.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000226","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000226/form4.xml","form_type":"4"}},{"id":1111116,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":11505,"kind":"person","name":"Karachun Rita A","position":1,"cik":"0001601572","reported_name":"Karachun Rita A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:48:48.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000225","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000225/form4.xml","form_type":"4"}},{"id":1111115,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:48:16.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000224/form4.xml","form_type":"4"}},{"id":1111969,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":21269,"kind":"person","name":"Newton Charles W.","position":1,"cik":"0001866219","reported_name":"Newton Charles W.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:47:41.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866219/000161071725000223/form4.xml","form_type":"4"}},{"id":1111114,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":35663,"kind":"person","name":"Satvat Ali J.","position":1,"cik":"0001621788","reported_name":"Satvat Ali J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:46:21.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000222","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000222/form4.xml","form_type":"4"}},{"id":1131791,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-28T21:12:50.000Z","date":"2025-05-23","kind":"sale","planned":false,"acquired":false,"shares":99988,"price":0.7389,"value":73881.1332,"ownership":{"direct":false,"nature":"Leonard Capital, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale transactions were effected for tax planning purposes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7362 to $0.7448, exclusive of any fees, commissions or other expenses. The Reporting Person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-25-000145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071725000145/form4.xml","form_type":"4"}},{"id":1153393,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-09T21:59:16.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":0.9462,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001610717-25-000117","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000117/form4.xml","form_type":"4"}},{"id":1153631,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-09T21:58:02.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":375000,"derivative":{"exercise_price":0.9462,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001610717-25-000116","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000116/form4.xml","form_type":"4"}},{"id":1297294,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-23T00:51:11.000Z","date":"2025-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1711,"price":1.39,"value":2378.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":22951,"source":{"system":"sec-edgar","filing":"0001610717-25-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000015/form4.xml","form_type":"4"}},{"id":1297293,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-23T00:49:54.000Z","date":"2025-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4858,"price":1.39,"value":6752.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":82069,"source":{"system":"sec-edgar","filing":"0001610717-25-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000014/form4.xml","form_type":"4"}},{"id":1297431,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-23T00:48:11.000Z","date":"2025-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":11810,"price":1.39,"value":16415.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":685074,"source":{"system":"sec-edgar","filing":"0001610717-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000013/form4.xml","form_type":"4"}},{"id":1303363,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:21:01.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 10, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":575000,"derivative":{"exercise_price":1.47,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001610717-25-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000011/form4.xml","form_type":"4"}},{"id":1304953,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-10T21:03:29.000Z","date":"2025-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1711,"price":1.57,"value":2686.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,401 shares acquired on May 15, 2023 pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":24662,"source":{"system":"sec-edgar","filing":"0001610717-25-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000010/form4.xml","form_type":"4"}},{"id":1307868,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-08T01:52:26.000Z","date":"2025-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":11810,"price":1.66,"value":19604.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":696884,"source":{"system":"sec-edgar","filing":"0001610717-25-000009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071725000009/form4.xml","form_type":"4"}},{"id":1307626,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T01:51:10.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":1.66,"expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-25-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000008/form4.xml","form_type":"4"}},{"id":1307625,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T01:50:18.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":1.66,"expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-25-000007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000007/form4.xml","form_type":"4"}},{"id":1307624,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-08T01:50:18.000Z","date":"2025-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2277,"price":1.66,"value":3779.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":86927,"source":{"system":"sec-edgar","filing":"0001610717-25-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000007/form4.xml","form_type":"4"}},{"id":1328207,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T21:44:12.000Z","date":"2024-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2073,"price":1.61,"value":3337.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares acquired on November 15, 2024 and 5,000 shares acquired on May 15, 2024, each pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":89204,"source":{"system":"sec-edgar","filing":"0001610717-24-000542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000542/form4.xml","form_type":"4"}},{"id":1436728,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-09T20:11:03.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of August 1, 2024 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.24,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001610717-24-000424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000424/form4.xml","form_type":"4"}},{"id":1449296,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-25T00:16:42.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":196500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 982,500 shares of common stock, of which 196,500 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise."}],"balance_after":196500,"derivative":{"exercise_price":2.41,"expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":196500},"source":{"system":"sec-edgar","filing":"0001610717-24-000406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000406/form4.xml","form_type":"4"}},{"id":1449239,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-25T00:14:40.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 200,000 shares of common stock, of which 40,000 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise."}],"balance_after":40000,"derivative":{"exercise_price":2.41,"expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001610717-24-000405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000405/form4.xml","form_type":"4"}},{"id":1489603,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":11505,"kind":"person","name":"Karachun Rita A","position":1,"cik":"0001601572","reported_name":"Karachun Rita A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:57:54.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/3rd of the total number of shares on the one year anniversary of June 4, 2024 and 1/36th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":168000,"derivative":{"exercise_price":1.78,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0001610717-24-000295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000295/form4.xml","form_type":"4"}},{"id":1489602,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:54:11.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":114000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/3rd of the total number of shares on the one year anniversary of June 4, 2024 and 1/36th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":114000,"derivative":{"exercise_price":1.78,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":114000},"source":{"system":"sec-edgar","filing":"0001610717-24-000293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000293/form4.xml","form_type":"4"}},{"id":1490295,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":21269,"kind":"person","name":"Newton Charles W.","position":1,"cik":"0001866219","reported_name":"Newton Charles W.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:52:49.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000292","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866219/000161071724000292/form4.xml","form_type":"4"}},{"id":1489601,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39971,"kind":"person","name":"Ryan Michael Lee","position":1,"cik":"0001985918","reported_name":"Ryan Michael Lee","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:51:30.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000291","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000291/form4.xml","form_type":"4"}},{"id":1489923,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:50:22.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000290/form4.xml","form_type":"4"}},{"id":1489760,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":28030,"kind":"person","name":"STOLPER MARK","position":1,"cik":"0001281961","reported_name":"STOLPER MARK","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:49:17.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000289","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281961/000161071724000289/form4.xml","form_type":"4"}},{"id":1489600,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:47:59.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000288","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000288/form4.xml","form_type":"4"}},{"id":1489599,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":28029,"kind":"person","name":"TZOUMAKAS KIMBERLY JO","position":1,"cik":"0001766666","reported_name":"TZOUMAKAS KIMBERLY JO","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:46:29.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000287","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000287/form4.xml","form_type":"4"}},{"id":1489597,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39970,"kind":"person","name":"O'Donnell-Tormey Jill","position":1,"cik":"0001927733","reported_name":"O'Donnell-Tormey Jill","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:45:11.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000286","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000286/form4.xml","form_type":"4"}},{"id":1624817,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T22:02:44.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from February 20, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":54000,"derivative":{"exercise_price":2.59,"expiration_date":"2034-02-20","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001610717-24-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000088/form4.xml","form_type":"4"}},{"id":1640895,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-16T00:56:46.000Z","date":"2024-02-09","kind":"gift","planned":false,"acquired":true,"shares":99988,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Leonard Capital, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer, for no consideration, of 99,988 shares directly owned by the Reporting Person to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC."}],"balance_after":99988,"source":{"system":"sec-edgar","filing":"0001610717-24-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000060/form4.xml","form_type":"4"}},{"id":1640894,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-16T00:56:46.000Z","date":"2024-02-09","kind":"gift","planned":false,"acquired":false,"shares":99988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer, for no consideration, of 99,988 shares directly owned by the Reporting Person to Leonard Capital, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-24-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000060/form4.xml","form_type":"4"}},{"id":1658675,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":44991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.667,"expiration_date":"2024-03-10","underlying":"Common Stock","underlying_shares":44991},"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1658674,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":14997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.667,"expiration_date":"2024-03-10","underlying":"Common Stock","underlying_shares":14997},"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1658673,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":44991,"price":1.667,"value":74999.997,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price."}],"balance_after":99988,"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1658672,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":14997,"price":1.667,"value":24999.999,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price."}],"balance_after":54997,"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1672936,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-24T01:07:16.000Z","date":"2024-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":11218,"price":2.44,"value":27371.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":708694,"source":{"system":"sec-edgar","filing":"0001610717-24-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000039/form4.xml","form_type":"4"}},{"id":1672750,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-24T01:05:42.000Z","date":"2024-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4854,"price":2.44,"value":11843.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":81277,"source":{"system":"sec-edgar","filing":"0001610717-24-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000038/form4.xml","form_type":"4"}},{"id":1672749,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-24T01:04:19.000Z","date":"2024-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1707,"price":2.44,"value":4165.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":22972,"source":{"system":"sec-edgar","filing":"0001610717-24-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000037/form4.xml","form_type":"4"}},{"id":1682348,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-10T00:37:09.000Z","date":"2024-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1707,"price":2.87,"value":4899.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":24679,"source":{"system":"sec-edgar","filing":"0001610717-24-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000023/form4.xml","form_type":"4"}},{"id":1684077,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-09T00:04:08.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 5, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":575000,"derivative":{"exercise_price":3.14,"expiration_date":"2034-01-05","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001610717-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000019/form4.xml","form_type":"4"}},{"id":1684076,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42365,"kind":"person","name":"Lanfear Dennis M","position":1,"cik":"0001420822","reported_name":"Lanfear Dennis M","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-09T00:04:08.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":11781,"price":2.92,"value":34400.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":719912,"source":{"system":"sec-edgar","filing":"0001610717-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420822/000161071724000019/form4.xml","form_type":"4"}},{"id":1683804,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-08T23:58:36.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2275,"price":2.92,"value":6643.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":86131,"source":{"system":"sec-edgar","filing":"0001610717-24-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000018/form4.xml","form_type":"4"}},{"id":1687131,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:14:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":3.14,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001610717-24-000012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000012/form4.xml","form_type":"4"}},{"id":1687130,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":83970,"kind":"person","name":"Reider Paul","position":1,"cik":"0001970033","reported_name":"Reider Paul","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:13:16.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":3.14,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-24-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000011/form4.xml","form_type":"4"}},{"id":1693063,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":95570,"kind":"person","name":"Stilwell McDavid","position":1,"cik":"0001851389","reported_name":"Stilwell McDavid","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T16:42:10.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":18440,"price":3.33,"value":61405.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,826 shares acquired on November 15, 2023, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan and includes the cancellation of 13,333 restricted stock units."}],"balance_after":75305,"source":{"system":"sec-edgar","filing":"0001610717-24-000001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851389/000161071724000001/form4.xml","form_type":"4"}}],"next_cursor":"2024-01-03T16:42:10.000000Z,1693063"}